Bekdash B, Harris S, Broughton C I, Caffarey S M, Marks C G
Department of Surgery, Royal Surrey County Hospital, Guildford, UK.
Br J Surg. 1997 Oct;84(10):1442-4.
Patients with primary colorectal cancers have a higher risk of development of second tumours synchronously or metachronously. This special group of patients raise a particular interest in their characteristics and outcome.
The records of 1009 patients with colorectal cancer were scrutinized. A group with multiple cancers was identified. Perioperative investigations, patterns of follow-up, pathological variables and outcome were noted.
There were 22 patients with metachronous tumours and 39 with synchronous tumours following 'curative' operations in 20 and 28 respectively. There was no difference in Dukes classification between the two groups: Polyps were associated with metachronous lesions in ten of 22 patients and synchronous lesions in 17 of 39 patients. Five-year survival was 75 per cent for patients with metachronous tumours and only 18 per cent for those with synchronous tumours.
In this study patients with metachronous tumours seemed to do very well while those with synchronous lesions did very badly. There were no identifiable demographic or clinical characteristics to account for this. There is a need to study this group of patients and identify factors like tumour biology or host resistance which prevent spread of tumour.
原发性结直肠癌患者发生同步或异时性第二肿瘤的风险更高。这类特殊患者群体因其特征和预后引发了特别关注。
对1009例结直肠癌患者的记录进行了仔细审查。确定了一组患有多种癌症的患者。记录了围手术期检查、随访模式、病理变量和预后情况。
分别有20例和28例患者在“根治性”手术后发生了异时性肿瘤,22例和39例发生了同步性肿瘤。两组患者的 Dukes 分期无差异:息肉在22例异时性病变患者中的10例以及39例同步性病变患者中的17例中出现。异时性肿瘤患者的五年生存率为75%,而同步性肿瘤患者仅为18%。
在本研究中,异时性肿瘤患者似乎预后良好,而同步性病变患者预后很差。没有可识别的人口统计学或临床特征来解释这一现象。有必要对这类患者进行研究,并确定如肿瘤生物学或宿主抵抗力等可阻止肿瘤扩散的因素。